H. Glossmann

发表

Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening.

Thierry Langer, Christian Laggner, Rémy D Hoffmann, 2005, Journal of medicinal chemistry.

Discovery of high-affinity ligands of σ1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening

Thierry Langer, Rémy D. Hoffmann, Christian Laggner, 2005 .

Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine

H. Glossmann, D. Ferry, 1983, Naunyn-Schmiedeberg's Archives of Pharmacology.

Neurotoxic aminoglycoside antibiotics are potent inhibitors of [125I]-Omega-Conotoxin GVIA binding to guinea-pig cerebral cortex membranes

A. Koza, H. Glossmann, J. Striessnig, 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3H]HOE166 defines a novel calcium antagonist drug receptor — distinct from the 1,4 dihydropyridine binding domain

M. Weiler, H. Glossmann, J. Striessnig, 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.

125I-iodipine*, a new high affinity ligand for the putative calcium channel

H. Glossmann, D. Ferry, 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacological Analysis of Sterol Δ8-Δ7 Isomerase Proteins with [3H]Ifenprodil

Y. Paik, S. Cho, H. Glossmann, 1998 .

High affinity of sigma1‐binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8–C7 isomerase

H. Glossmann, F. F. Moebius, F F Moebius, 1997, British journal of pharmacology.

Very high affinity interaction of DPI 201‐106 and BDF 8784 enantiomers with the phenylalkylamine‐sensitive Ca2+‐channel in Drosophila head membranes

C. Zech, R. Staudinger, R. Greenberg, 1991, British journal of pharmacology.

Hydrophobic calcium channel ligands: methodical problems and their solution.

G. Zernig, H. Glossmann, A. Grassegger, 1989, The American journal of cardiology.

(+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of α1-adrenoceptors

H. Glossmann, A. Grassegger, R. Boer, 1989 .

Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heart

H. Glossmann, D. Ferry, A. Kaumann, 1985, British journal of pharmacology.

Pharmacological analysis of sterol delta8-delta7 isomerase proteins with [3H]ifenprodil.

Y. Paik, S. Cho, H. Glossmann, 1998, Molecular pharmacology.

Visualization of the domain structure of an L-type Ca2+ channel using electron cryo-microscopy.

N. Grigorieff, M. Wolf, H. Glossmann, 2003, Journal of molecular biology.

Expression of the purported sigma1 (σ1) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy

R. Quirion, J. Chabot, K. Kitaichi, 2000, Journal of Chemical Neuroanatomy.

Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies.

E. Schmid, H. Glossmann, F. F. Moebius, 1993, Molecular pharmacology.

Biochemical characterization of a 22-kDa high affinity antiischemic drug-binding polypeptide in the endoplasmic reticulum of guinea pig liver: potential common target for antiischemic drug action.

H. Glossmann, F. F. Moebius, J. Striessnig, 1993, Molecular pharmacology.

Renal receptors for calcitonin. Binding and degradation of hormone.

C. Woodward, H. Keutmann, S. Marx, 1973, The Journal of biological chemistry.

Soluble bovine adrenal cortex guanylate cyclase: Effect of sodium nitroprusside, nitrosamines, and hydrophobic ligands on activity, substrate specificity and cation requirement

H. Glossmann, C. Struck, 1978, Naunyn-Schmiedeberg's Archives of Pharmacology.

Glycoproteins of cell surfaces. A comparative study of three different cell surfaces of the rat.

D. Neville, H. Glossmann, 1971, The Journal of biological chemistry.

[35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties.

H. Höltje, H. Glossmann, J. Striessnig, 1992, Molecular pharmacology.

Molecular weight determination of membrane protein and glycoprotein subunits by discontinuous gel electrophoresis in dodecyl sulfate.

D. Neville, H. Glossmann, 1974, Methods in enzymology.

Block of P/Q-type calcium channels by therapeutic concentrations of aminoglycoside antibiotics.

H. Glossmann, J. Striessnig, S. Hering, 1996, Biochemistry.

Mutations in the gene encoding 3β-hydroxysteroid-Δ 8,Δ7-isomerase cause X-linked dominant Conradi-Hünermann syndrome

A. Moser, C. Obie, D. Valle, 1999, Nature Genetics.

Three New Familial Hemiplegic Migraine Mutants Affect P/Q-type Ca2+ Channel Kinetics*

A. Koschak, S. Stenirri, R. Kraus, 2000, The Journal of Biological Chemistry.

[3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.

H. Glossmann, D. Ferry, P. Bellemann, 1982, Arzneimittel-Forschung.

Subunit composition of skeletal muscle transverse tubule calcium channels evaluated with the 1,4‐dihydropyridine photoaffinity probe, [3H]azidopine.

H. Glossmann, D. Ferry, K. Kämpf, 1985, The EMBO journal.

A light stabilizer (Tinuvin 770) that elutes from polypropylene plastic tubes is a potent L-type Ca(2+)-channel blocker.

G. Kaczorowski, H. Glossmann, J. Liesch, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Molecular pharmacology of the calcium channel

H. Glossmann, D. Ferry, A. Goll, 1984 .

Glycolysis—one of the keys to cancer?

E. Eigenbrodt, H. Glossmann, 1980 .

Inhibition of cardiac L-type calcium channels by quaternary amlodipine: implications for pharmacokinetics and access to dihydropyridine binding site.

Y. Kwan, R. Kass, H. Glossmann, 1995, Journal of molecular and cellular cardiology.

Structure of Calcium Channels a

H. Schindler, H. Höltje, H. Glossmann, 1989, Annals of the New York Academy of Sciences.

Purification and Reconstitution of Calcium Channel Drug‐Receptor Sites a

H. Schindler, H. Glossmann, J. Striessnig, 1988, Annals of the New York Academy of Sciences.

Methods in Pharmacology

H. Glossmann, J. Striessnig, 1993, Springer US.

Angiotensin II receptors in bovine adrenal cortex. Modification of angiotensin II binding by guanyl nucleotides.

K. Catt, H. Glossmann, A. Baukal, 1974, The Journal of biological chemistry.

The Structure of the Ca2+ Channel: Photoaffinity Labeling and Tissue Distribution

H. Schindler, G. Zernig, H. Glossmann, 1988 .

Heparin binds with high affinity to voltage-dependent L-type Ca2+ channels. Evidence for an agonistic action.

C. Romanin, H. Schindler, H. Glossmann, 1990, The Journal of biological chemistry.

γ‐Glutamyltransferase in kidney brush border membranes

D. Neville, H. Glossmann, Hartmut Glossmann, 1972 .

Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.

R. Staudinger, H. Glossmann, H. Knaus, 1991, The Journal of biological chemistry.

Molecular genetics of the Smith-Lemli-Opitz syndrome and postsqualene sterol metabolism.

G. Utermann, H. Glossmann, F. F. Moebius, 1999, Current opinion in lipidology.

Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome.

G. Utermann, Y. Paik, M. Witsch-Baumgartner, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Interaction Between Calcium Channel Ligands and Calcium Channels

H. Glossmann, J. Striessnig, D. Ferry, 1987, Circulation research.

Photoaffinity labelling of Ca2+ channels with [3H]azidopine

H. Glossmann, D. Ferry, A. Goll, 1984, FEBS letters.

Genetic Defects in Postsqualene Cholesterol Biosynthesis

H. Glossmann, F. F. Moebius, B. Fitzky, 2000, Trends in Endocrinology & Metabolism.

alpha-Adrenoceptors in rat brain: sodium changes the affinity of agonists for prazosin sites.

H. Glossmann, R. Hornung, 1980, European journal of pharmacology.

Identification of putative calcium channels in skeletal muscle microsomes

H. Glossmann, D. Ferry, 1982, FEBS letters.

Calcium channels: The β‐subunit increases the affinity of dihydropyridine and Ca2+ binding sites of the α1‐subunit

H. Glossmann, J. Striessnig, M. Grabner, 1994 .

Insect calcium channels

D. Tautz, A. Bachmann, C. Schulz, 1994 .

Cation sensitivity of [125I]heat binding to α1-adrenoceptors in rat cerebral cortex membranes

H. Glossmann, P. Presek, P. Bellemann, 1981 .

Plasma membrane protein subunit composition. A comparative study by discontinuous electrophoresis in sodium dodecyl sulfate.

D. Neville, H. Glossmann, 1971, The Journal of biological chemistry.

Molecular cloning and expression of the human delta7-sterol reductase.

Joon-No Lee, Y. Paik, H. Glossmann, 1998 .

The increase in hormone‐stimulated adenylate cyclase activity following rous sarcoma virus transformation

H. Glossmann, R. Friis, J. Sheppard, 1982, Journal of cellular physiology.

Endogenous calcium channels in human embryonic kidney (HEK293) cells

F. Döring, H. Glossmann, S. Berjukow, 1996, British journal of pharmacology.

Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter.

G. Zernig, H. Glossmann, J. Striessnig, 1985, European journal of biochemistry.

Quercetin inhibits tyrosine phosphorylation by the cyclic nucleotide-independent, transforming protein kinase, pp60src

E. Eigenbrodt, H. Glossmann, P. Presek, 1981, Naunyn-Schmiedeberg's Archives of Pharmacology.

Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.

T. Langer, H. Glossmann, J. Striessnig, 2000, The Biochemical journal.

Sequence Differences between α1C and α1S Ca2+ Channel Subunits Reveal Structural Determinants of a Guarded and Modulated Benzothiazepine Receptor*

H. Glossmann, S. Berjukow, S. Hering, 1999, The Journal of Biological Chemistry.

Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit.

H. Glossmann, J. Striessnig, M. Grabner, 1995, Biochemistry.

Evidence for an external location of the dihydropyridine agonist receptor site on smooth muscle and skeletal muscle calcium channels

C. Strübing, H. Glossmann, S. Hering, 1993, British journal of pharmacology.

Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations.

K. Itagaki, A. Schwartz, H. Glossmann, 1987, The Journal of biological chemistry.

Research letters(—)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe: Binding characteristics and target size analysis of its receptor in skeletal muscle

H. Glossmann, J. Striessnig, D. Ferry, 1984 .

Functional Consequences of P/Q-type Ca2+Channel Cav2.1 Missense Mutations Associated with Episodic Ataxia Type 2 and Progressive Ataxia*

A. Koschak, M. Poteser, R. Kraus, 2002, The Journal of Biological Chemistry.

STRUCTURE AND PHARMACOLOGY OF VOLTAGE - DEPENDENT CALCIUM

H. Glossmann, J. Striessnig, 1988 .

Assay for calcium channels.

H. Glossmann, D. Ferry, 1985, Methods in enzymology.

Chimeric L‐type Ca2+ channels expressed in Xenopus laevis oocytes reveal role of repeats III and IV in activation gating.

H. Glossmann, S. Berjukow, S. Hering, 1995, The Journal of physiology.

Molecular Properties of Voltage-Dependent Ca2+ Channels in Excitable Tissues

H. Glossmann, J. Striessnig, W. Berger, 1993 .

A novel 1,4-dihydropyridine-binding site on mitochondrial membranes from guinea-pig heart, liver and kidney.

G. Zernig, H. Glossmann, 1988, The Biochemical journal.

Calcium Channel Blocking Agents

H. Glossmann, J. Striessnig, 2005 .

Identification of the benzothiazepine-binding polypeptide of skeletal muscle calcium channels with (+)-cis-azidodiltiazem and anti-ligand antibodies.

H. Glossmann, J. Striessnig, J. Mitterdorfer, 1990, The Journal of biological chemistry.

Calcium channels and calcium channel drugs: recent biochemical and biophysical findings.

G. Zernig, H. Glossmann, J. Striessnig, 1985, Arzneimittel-Forschung.

[125I] N6-p-hydroxyphenylisopropyladenosine, a new ligand for Ri adenosine receptors

D. Ukena, H. Glossmann, D. Ferry, 1982, Naunyn-Schmiedeberg's Archives of Pharmacology.

[125I]-HEAT, a selective, high-affinity, high specific activity ligand for alpha1-adrenoceptors

H. Glossmann, P. Bellemann, F. Lübbecke, 1981, Naunyn-Schmiedeberg's Archives of Pharmacology.

Ionic Modulation of α-Adrenoceptors

H. Glossmann, P. Bellemann, F. Lübbecke, 1982 .

Cation Dependence of High-Affinity Angiotensin II Binding to Adrenal Cortex Receptors

K. Catt, H. Glossmann, A. Baukal, 1974, Science.

Naftopidil, a New α‐Adrenoceptor Blocking Agent with Calcium Antagonistic Properties: Characterization of Ca2+ Antagonistic Effects

U. Ravens, H. Glossmann, H. Himmel, 1991, Journal of cardiovascular pharmacology.

Calcium Channels: Introduction into Their Molecular Pharmacology

G. Zernig, H. Glossmann, J. Striessnig, 1985 .

Mitochondrial Ca2+ antagonist binding sites are associated with an inner mitochondrial membrane anion channel.

C. Zech, G. Zernig, H. Glossmann, 1990, Molecular pharmacology.

Evidence for multiple receptor sites within the putative calcium channel

H. Glossmann, D. Ferry, 1982, Naunyn-Schmiedeberg's Archives of Pharmacology.

Phlorizin receptors in isolated kidney brush border membranes.

D. Neville, H. Glossmann, 1972, The Journal of biological chemistry.

Mutational Spectrum in the Δ7-Sterol Reductase Gene and Genotype-Phenotype Correlation in 84 Patients with Smith-Lemli-Opitz Syndrome

U. Seedorf, P. Clayton, G. Utermann, 2000 .

E. Eigenbrodt, W. Schoner, H. Glossmann, 1980, Cancer research.

Pharmacology and structure of high conductance calcium-activated potassium channels.

G. Kaczorowski, H. Glossmann, H. Knaus, 1994, Cellular signalling.

[14] - Purification of L-Type Calcium Channel Drug Receptors

H. Glossmann, J. Striessnig, 1991 .

Molecular properties of calcium channels.

H. Glossmann, J. Striessnig, 1990, Reviews of physiology, biochemistry and pharmacology.

Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.

T. Langer, H. Glossmann, J. Striessnig, 2000, The Biochemical journal.

Structural basis of drug binding to L Ca2+ channels.

H. Glossmann, J. Striessnig, S. Hering, 1998, Trends in pharmacological sciences.

[Data on sweet almond emulsin. Further characterization of components A and B].

T. Kleinschmidt, H. Glossmann, J. Horst, 1970, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

Stereospecific regulation of [3H]inositol monophosphate accumulation by calcium channel drugs from all three main chemical classes.

G. Zernig, H. Glossmann, T. Moshammer, 1986, European journal of pharmacology.

Alpha adrenoceptors in rat brain: Direct identification with prazosin

H. Glossmann, P. Presek, R. Hornung, 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel.

H. Glossmann, J. Striessnig, D. Ferry, 1986, European journal of biochemistry.

Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine.

W. Catterall, H. Glossmann, H. Nakayama, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Calcium- and potassium-channel blockers interact with α-adrenoceptors

H. Glossmann, R. Hornung, 1980, Molecular and Cellular Endocrinology.

I. General Papers Ii. Applications 1. Mrna Target A. Dna Probe A. Rpl

Aida, R. Tjian, Y. Jan, 2022 .

Calcium channels: direct identification with radioligand binding studies

F. Hofmann, H. Glossmann, D. Ferry, 1982 .

Alpha 2 adrenoceptors in rat brain: the divalent cation site.

H. Glossmann, R. Hornung, 1980, Naunyn-Schmiedeberg's archives of pharmacology.

Histidine77, glutamic acid81, glutamic acid123, threonine126, asparagine194, and tryptophan197 of the human emopamil binding protein are required for in vivo sterol delta 8-delta 7 isomerization.

G. Bonn, B. Fiechtner, H. Glossmann, 1999, Biochemistry.

Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hünermann syndrome.

A. Moser, C. Obie, D. Valle, 1999, Nature genetics.

Cloning of an emopamil-binding protein (EBP)-like protein that lacks sterol 7 isomerase activity

H. Glossmann, F. F. Moebius, G. Wietzorrek, 2003 .

Phenylalkylamine Ca2+ Antagonist Binding Protein

H. Glossmann, F. F. Moebius, J. Striessnig, 1995, The Journal of Biological Chemistry.

The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis.

H. Glossmann, F. F. Moebius, F F Moebius, 1997, Trends in pharmacological sciences.

Purification, molecular cloning, and expression of the mammalian sigma1-binding site.

E. Kempner, H. Glossmann, F. F. Moebius, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Purification and amino-terminal sequencing of the high affinity phenylalkylamine Ca2+ antagonist binding protein from guinea pig liver endoplasmic reticulum.

H. Glossmann, F. F. Moebius, J. Striessnig, 1994, The Journal of biological chemistry.

Binding of 3H-desmethylphalloin to isolated plasma membranes from rat liver

H. Glossmann, M. Frimmer, F. Lutz, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

α1D (Cav1.3) Subunits Can Form L-type Ca2+ Channels Activating at Negative Voltages*

A. Koschak, J. Engel, H. Glossmann, 2001, The Journal of Biological Chemistry.

Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels.

W. Catterall, H. Glossmann, J. Striessnig, 1990, Proceedings of the National Academy of Sciences of the United States of America.

The preparation of brush border membranes from rat kidney using an aqueous two-phase polymer system

H. Glossmann, H. Gips, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome.

N. Maeda, K. Sulik, K. Kluckman, 2001, The Journal of clinical investigation.

Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance.

S. Hofer, V. Gekeler, H. Glossmann, 1995, Biochemical pharmacology.

Bovine adrenal cortex adenylate cyclase: Properties of the particulate enzyme and effects of guanyl nucleotides

H. Glossmann, H. Gips, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Properties of angiotensin II receptors in the bovine and rat adrenal cortex.

K. Catt, H. Glossmann, A. Baukal, 1974, The Journal of biological chemistry.

Solubilization of a mammalian β-adrenergic receptor

H. Glossmann, J. Kleinstein, 1978, Naunyn-Schmiedeberg's Archives of Pharmacology.

Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.

H. Glossmann, D. Ferry, A. Goll, 1984, Journal of cardiovascular pharmacology.

Calcium- and potassium-channel blockers interact with alpha-adrenoceptors.

H. Glossmann, R. Hornung, 1980, Molecular and cellular endocrinology.

Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome.

U. Seedorf, P. Clayton, G. Utermann, 2000, American journal of human genetics.

Yeast sterol C8-C7 isomerase: identification and characterization of a high-affinity binding site for enzyme inhibitors.

H. Glossmann, F. F. Moebius, R. J. Reiter, 1996, Biochemistry.

[POLAROGRAPHIC MEASUREMENTS OF RESPIRATION DURING LOW OXYGEN PRESSURES].

H. Glossmann, D. Hegner, 1965, Zeitschrift fur Naturforschung. Teil B, Chemie, Biochemie, Biophysik, Biologie und verwandte Gebiete.

Molecular cloning and expression of the human delta7-sterol reductase.

Y. Paik, H. Glossmann, F. F. Moebius, 1998 .

Familial Hemiplegic Migraine Mutations Change α1ACa2+ Channel Kinetics*

R. Kraus, H. Glossmann, J. Striessnig, 1998, The Journal of Biological Chemistry.

Radioligand assay for angiotensin II receptors.

K. Catt, G. Aguilera, H. Glossmann, 1985, Methods in enzymology.

Effect of oc-adrenoceptor agonists on cell membrane potential in renal epitheloid Madin Darby canine kidney cells

F. Lang, E. Wöll, M. Paulmichl, 1991 .

Targeting the Kv1.3 potassium channel for immunosuppression in vascularized composite allotransplantation – a pilot study

F. Messner, C. Seger, A. Griesmacher, 2013, Transplant international : official journal of the European Society for Organ Transplantation.

Characteristics of the binding of the antihypertensive agent moxonidine to alpha 2-adrenoceptors in rat brain membranes.

H. Glossmann, D. Ferry, B. Armah, 1988, Arzneimittel-Forschung.

Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling

C. Sutherland, S. Schweiger, S. Krauß, 2010, Proceedings of the National Academy of Sciences.

Identification of voltage operated calcium channels by binding studies: differentiation of subclasses of calcium antagonist drugs with 3H-nimodipine radioligand binding.

F. Hofmann, H. Glossmann, D. Ferry, 1983, Journal of receptor research.

The Use of Ligand Binding for the Characterisation of &agr;‐Adrenoceptors

H. Glossmann, P. Presek, R. Hornung, 1980 .

Molecular Basis of Drug Interaction with L-Type Ca2+ Channels

H. Prinz, R. Kraus, H. Glossmann, 1998, Journal of bioenergetics and biomembranes.

Recent Developments in the Molecular Characterization of the L-Type Ca2+ -Channel and Mitochondrial Ca2+-Antagonist Sites

C. Zech, G. Zernig, H. Glossmann, 1990 .

Cloning of an emopamil-binding protein (EBP)-like protein that lacks sterol delta8-delta7 isomerase activity.

H. Glossmann, F. F. Moebius, G. Wietzorrek, 2003, The Biochemical journal.

Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics.

R. Kraus, H. Glossmann, J. Striessnig, 1998, The Journal of biological chemistry.

Nine L-type Amino Acid Residues Confer Full 1,4-Dihydropyridine Sensitivity to the Neuronal Calcium Channel α1ASubunit

H. Glossmann, J. Striessnig, S. Hering, 1997, The Journal of Biological Chemistry.

Distribution of high-conductance Ca(2+)-activated K+ channels in rat brain: targeting to axons and nerve terminals

O. Pongs, G. Sperk, C. Schwarzer, 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Investigations on the mechanism of cyclic guanosine monophosphate increase due to depolarizing agents as studied with sea anemone toxin II in mouse cerebellar slices

H. Glossmann, E. Habermann, G. Ahnert, 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

Effects of ion channel toxins and specific neurotoxins on the cyclic nucleotide content of cerebellar slices, primary brain cultures and neural cell lines

H. Glossmann, E. Habermann, G. Ahnert, 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

Adrenal cortex adenylate cyclase

H. Glossmann, C. Struck, H. Glossmann, 1977, Naunyn-Schmiedeberg's Archives of Pharmacology.

Adrenal cortex adenylate cyclase

H. Glossmann, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[On the question of native hemoglobins in the larvae of Chironomus thummi thummi].

H. Glossmann, G. Braunitzer, J. Horst, 1968, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

Cloning and functional expression of a neuronal calcium channel beta subunit from house fly (Musca domestica).

H. Glossmann, P. Charnet, S. Hering, 1994, The Journal of biological chemistry.

Native and detergent-solubilized membrane extracts from Drosophila heads contain binding sites for phenylalkylamine calcium channel blockers

A. Koza, R. Greenberg, H. Glossmann, 1989 .

Calcium Channel Toxins

H. Glossmann, J. Striessnig, 1994 .

Ca2+ antagonist receptor sites on human red blood cell membranes.

G. Zernig, H. Glossmann, J. Striessnig, 1985, European journal of pharmacology.

Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart

R. Mannhold, H. Glossmann, A. Goll, 1986, Naunyn-Schmiedeberg's Archives of Pharmacology.

(—)‐[3H]Desmethoxyverapamil, a novel Ca2+ channel probe

H. Glossmann, J. Striessnig, D. Ferry, 1984, FEBS letters.

Calcium Channels: Basic Properties as Revealed by Radioligand Binding Studies

H. Glossmann, J. Striessnig, D. Ferry, 1985, Journal of cardiovascular pharmacology.

Mammalian beta-adrenoceptors: concomitant biospecific elution with protein kinase activity from Sepharose-alprenolol.

H. Glossmann, O. Bonacker, 1981, European journal of pharmacology.

Temperature‐dependent regulation of d‐cis‐[3H]diltiazem binding to Ca2+ channels by 1,4‐dihydropyridine channel agonists and antagonists

T. Linn, H. Glossmann, D. Ferry, 1983, FEBS Letters.

(−)-3H-desmethoxyverapamil labelling of putative calcium channels in brain: autoradiographic distribution and allosteric coupling to 1,4-dihydropyridine and diltiazem binding sites

H. Glossmann, D. Ferry, A. Goll, 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.

Benzothiazepine binding domain of purified L-type calcium channels: direct labeling using a novel fluorescent diltiazem analogue.

S. D. Kimball, Z. Cai, R. Haugland, 1995, Biochemistry.

The molecular pharmacology and structural features of calcium channels.

H. Glossmann, D. Ferry, A. Goll, 1985, British journal of clinical pharmacology.

Target size analysis and molecular properties of Ca2+ channels labelled with [3H]verapamil.

H. Glossmann, D. Ferry, A. Goll, 1984, European journal of biochemistry.

Purified calcium channels have three allosterically coupled drug receptors

H. Glossmann, J. Striessnig, A. Goll, 1986, FEBS letters.

Molecular approach to the calcium channel.

T. Linn, H. Glossmann, D. Ferry, 1985, Advances in myocardiology.

Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110

H. Glossmann, D. Ferry, A. Goll, 1983, Naunyn-Schmiedeberg's Archives of Pharmacology.

Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse‐tubule calcium channel

H. Glossmann, J. Striessnig, H. Knaus, 1987, FEBS letters.

Molecular Pharmacology of Calcium Channel Modulation

C. Zech, G. Zernig, H. Glossmann, 1989 .

Transfer of 1,4-Dihydropyridine Sensitivity from L-Type to Class A (BI) Calcium Channels

H. Glossmann, J. Striessnig, S. Hering, 1996, Neuron.

Calcium channels from Cyprinus carpio skeletal muscle.

W. Koch, R. Staudinger, A. Schwartz, 1991, Proceedings of the National Academy of Sciences of the United States of America.

A Molecular Model of Excitation‐Contraction Coupling at the Skeletal Muscle Triad Junction via Coassociated Oligomeric Calcium Channels a

S. Fleischer, H. Schindler, M. Inui, 1989 .

Association of calcium channel α1S and β1a subunits is required for the targeting of β1a but not of α1S into skeletal muscle triads

B. Flucher, F. Döring, T. Tanabe, 1998 .

Differential Effects of Ca2+ Channel β1a and β2a Subunits on Complex Formation with α1S and on Current Expression in tsA201 Cells*

B. Flucher, H. Glossmann, B. Neuhuber, 1998, The Journal of Biological Chemistry.

Resolving the structure of the Ca2+ channel by photoaffinity labelling

H. Glossmann, J. Striessnig, D. Ferry, 1987 .

Molecular cloning and expression of the human D7-sterol reductase

Bárbara, F., H. Glossmann, 1998 .

Two Amino Acid Residues in the IIIS5 Segment of L-Type Calcium Channels Differentially Contribute to 1,4-Dihydropyridine Sensitivity*

H. Glossmann, S. Hering, M. Grabner, 1996, The Journal of Biological Chemistry.

Novel 1,4‐Dihydropyridine (Bay K 8644) Facilitates Calcium‐Dependent [3H]Noradrenaline Release from PC 12 Cells

H. Glossmann, D. Ferry, U. Albus, 1984, Journal of neurochemistry.

Association of the src-gene product of rous sarcoma virus with a pyruvate-kinase inactivating factor

E. Eigenbrodt, H. Glossmann, Peter Presejk, 1981, Molecular and Cellular Endocrinology.

Calcium channels: evidence for oligomeric nature by target size analysis.

H. Glossmann, D. Ferry, A. Goll, 1983, The EMBO journal.

Target size analysis of skeletal muscle Ca2+ channels

H. Glossmann, D. Ferry, A. Goll, 1983, FEBS letters.

Phlorizin receptors in isolated kidney brush border membranes. Differential enzymatic modification of high-affinity receptors and unspecific binding sites.

D. Neville, H. Glossmann, 1973, Biochimica et biophysica acta.

Putative calcium channel molecular weight determination by target size analysis

H. Glossmann, D. Ferry, A. Goll, 1983, Naunyn-Schmiedeberg's Archives of Pharmacology.

Radiation inactivation of alpha1-adrenoceptors

H. Glossmann, D. Ferry, F. Lübbecke, 1983, Naunyn-Schmiedeberg's Archives of Pharmacology.

β-Adrenergic receptors in guinea-pig myocardial tissue

E. Erdmann, H. Glossmann, D. Poppert, 1976, Naunyn-Schmiedeberg's Archives of Pharmacology.

Adrenal cortex adenylate cyclase

H. Glossmann, C. Struck, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

WIN 17317-3, a new high-affinity probe for voltage-gated sodium channels.

V. Warren, G. Kaczorowski, H. Glossmann, 1999, Biochemistry.

Purified skeletal muscle 1,4-dihydropyridine receptor forms phosphorylation-dependent oligomeric calcium channels in planar bilayers.

H. Schindler, H. Glossmann, J. Striessnig, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Analysis of membrane protein self-association in lipid systems by fluorescence particle counting: application to the dihydropyridine receptor.

H. Gruber, H. Schindler, P. Hinterdorfer, 1997, Biochemistry.

Identification of PK-A phosphorylation sites in the carboxyl terminus of L-type calcium channel alpha 1 subunits.

H. Glossmann, F. F. Moebius, J. Striessnig, 1996, Biochemistry.

In vivo labeling of L-type Ca2+ channels by fluorescent dihydropyridines: evidence for a functional, extracellular heparin-binding site.

H. Glossmann, H. Knaus, T. Moshammer, 1992, Proceedings of the National Academy of Sciences of the United States of America.

A unique fluorescent phenylalkylamine probe for L-type Ca2+ channels. Coupling of phenylalkylamine receptors to Ca2+ and dihydropyridine binding sites.

R. Haugland, H. Glossmann, H. Knaus, 1992, The Journal of biological chemistry.

Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67.

C. Romanin, H. Schindler, H. Glossmann, 1993, Molecular pharmacology.

L-type calcium channels and calcium channel ligands

H. Glossmann, J. Striessnig, 1992 .

The dihydropyridine niguldipine inhibits T-type Ca2+ currents in atrial myocytes

C. Romanin, H. Schindler, H. Glossmann, 1992, Pflügers Archiv.

Molecular structure of rat brain apamin receptor: differential photoaffinity labeling of putative K+ channel subunits and target size analysis.

C. Granier, F. Couraud, H. Glossmann, 1986, Biochemistry.

Characterization of the drug receptors of the purified skeletal muscle calcium channel.

H. Glossmann, J. Striessnig, 1988, Progress in clinical and biological research.

Transfer of High Sensitivity for Benzothiazepines from L-type to Class A (BI) Calcium Channels*

F. Döring, H. Glossmann, J. Striessnig, 1996, The Journal of Biological Chemistry.

Transfer of L-type Calcium Channel IVS6 Segment Increases Phenylalkylamine Sensitivity of (*)

F. Döring, H. Glossmann, J. Striessnig, 1996, The Journal of Biological Chemistry.

Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel.

H. Glossmann, J. Striessnig, H. Knaus, 1988, The Biochemical journal.

The identification of cytoplasmic membrane calcium-entry channels by ligand-binding studies.

H. Glossmann, D. Ferry, A. Goll, 1984, Biochemical Society transactions.

(+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptors.

H. Glossmann, A. Grassegger, R. Boer, 1989, European journal of pharmacology.

Alpha2 adrenoceptors in rat brain

H. Glossmann, R. Hornung, 1980, Naunyn-Schmiedeberg's Archives of Pharmacology.

Beta-adrenergic receptors in guinea-pig myocardial tissue.

E. Erdmann, H. Glossmann, D. Poppert, 1976, Naunyn-Schmiedeberg's archives of pharmacology.

Cyanogen bromide cleavage of Proteus mirabilis flagellin. Maleylation of cyanogen bromide peptides.

W. Bode, H. Glossmann, 1972, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

Novel sites for phenylalkylamines: characterisation of a sodium-sensitive drug receptor with (-)-[3H]emopamil.

C. Zech, R. Staudinger, H. Glossmann, 1991, European journal of pharmacology.

Improved micro-perfusion chamber for multiple and rapid solution exchange in adherent single cells

H. Glossmann, S. Hering, A. Savchenko, 2004, Pflügers Archiv.

Purification of the putative calcium channel from skeletal muscle with the aid of [3H]-nimodipine binding

H. Glossmann, D. Ferry, C. Bruce Boschek, 1983, Naunyn-Schmiedeberg's Archives of Pharmacology.